Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Pediatr Hematol Oncol ; 45(5): e628-e630, 2023 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-36730621

RESUMO

The posttransplant lymphoproliferative disease is a severe cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. Central Nervous System involvement in EBV-related PTLD is rare, and there is no standard treatment recommendation. We present our patient and discuss other previously reported cases of EBV-associated PTLD with CNS involvement.


Assuntos
Infecções por Vírus Epstein-Barr , Transplante de Células-Tronco Hematopoéticas , Transtornos Linfoproliferativos , Humanos , Rituximab/uso terapêutico , Herpesvirus Humano 4 , Infecções por Vírus Epstein-Barr/complicações , Infecções por Vírus Epstein-Barr/tratamento farmacológico , Transtornos Linfoproliferativos/etiologia , Transtornos Linfoproliferativos/complicações , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Sistema Nervoso Central
2.
Iran J Public Health ; 51(8): 1836-1846, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-36249118

RESUMO

Background: Breast cancer is a heterogeneous disease and differences in the expression levels of the ER, PR, and HER2 the triplet of established biomarkers used for clinical decision-making have been reported among breast cancer patients. Furthermore, resistance to anti-estrogen and anti-HER2 therapies emerges in a considerable rate of breast cancer patients, and novel drug therapies are required. Several anomalous signaling pathways have been known in breast cancer have been known; heat shock protein 90 (HSP90) is one of the most plenty proteins in breast cells. The family of ubiquitin ligases such as SIAH1 and SIAH2 is known to specifically target misfolded proteins to the proteasome; also, they have been illustrated to play a role in RAS signaling and as an essential downstream signaling component required for EGFR/HER2 in breast cancer. Methods: The expression of SIAH2, HSP90, and HER2 was assessed by quantitative Real-Time PCR in 85 invasive ductal carcinoma breast tumor samples at Uludag University Hospital in Turkey during the years 2018-2019, and its association with the clinicopathologic variables of patients was evaluated. Results: HSP90, SIAH1, and SIAH2 were significantly (P=0.0271, P=0.022, and P=0.0311) upregulated tumor tissue of patients with breast cancer. Moreover, this study observed a significant association between the high expression of SIAH2/HSP90 with ER status, high expression of HSP90 with Recurrence/Metastasis, and high expression of SIAH2 with Ki-67 proliferation index. Conclusion: The HSP90 and SIAH2 expressions play a significant role in breast cancer development by combining the experimental and clinical data obtained from the literature.

3.
Mol Biol Rep ; 49(3): 2073-2083, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34851479

RESUMO

BACKGROUND: Clear cell type renal cell carcinoma (ccRCC) is the most common renal cell carcinoma (RCC). In this study, we examined the expressions of VHL and miR-223 in ccRCC patients׳ tissues to investigate the possible role in the development of ccRCC. METHODS AND RESULTS: This study collected five expression profiles (GSE36139, GSE3, GSE73731, GSE40435, and GSE26032) from Gene Omnibus Data. Expressions of VHL and miR-223 in paraffinized tumor and normal tissues of 100 Turkish patients' ccRCC tissues were determined by bioinformatic data mining and real-time quantitative polymerase chain reaction (qRT-PCR). The VHL gene was subjected to mutational analysis by DNA sequencing, and pVHL was analyzed using western blotting. Our study's t-test and Pearson correlation analysis showed that VHL gene expression in tumoral tissues with a - 0.39-fold decrease was not significantly lower than normal tissues (p = 0.441), and a 0.97-fold increase miR-223 (p = 0.045) was determined by real-time PCR. Also, as a result of DNA sequence analysis performed in the VHL gene, it was found that 26% of the patients have mutations. The mutations for (VHL):c.60C>A (p.Val20=) and (VHL):c.467delA (p.Tyr156Leu) was detected for the first time in Turkish patients. CONCLUSIONS: The present study demonstrated that the differences in the expression levels of miR-223 have the potential to be biomarkers to determine the poor prognosis in ccRCC.


Assuntos
Carcinoma de Células Renais , Neoplasias Renais , MicroRNAs , Carcinoma de Células Renais/metabolismo , Humanos , Neoplasias Renais/metabolismo , MicroRNAs/genética , Mutação/genética , Análise de Sequência de DNA , Proteína Supressora de Tumor Von Hippel-Lindau/genética
4.
J BUON ; 23(4): 1125-1129, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30358221

RESUMO

PURPOSE: Upregulation of N-cadherin in epithelial tumor cells has been reported to enhance the invasive process. Although the distribution of N-cadherin in the normal testis was demonstrated, there is no adequate information regarding its presence in testicular germ cell tumors (GCTs). Our purpose was to examine the expression and localization of N-cadherin in germ cell tumors of the testis and share our experience. METHODS: 104 adult cases of primary and metastatic testicular GCTs, 5 germ cell neoplasia in situ and 15 benign testicular tissues were included into the study and analyzed for immunoexpression of N-cadherin. Positive expression was evaluated according to intensity and localization of the staining. RESULTS: In 34 pure seminomas, 6 seminomas of mixed component and 16 metastatic seminomas, N-cadherin expression was observed with variable staining intensity. Two pure yolk sac tumors and 20 out of 34 mixed GCTs with yolk sac components were positive for N-cadherin. In contrast, neither the embryonal and chorionic carcinomas nor the teratomas showed N-cadherin expression. CONCLUSIONS: N-cadherin immunexpression should be interpreted considering both staining intensity and extent. In case of a metastatic tumor of unknown primary showing prominent N-cadherin expression, seminoma should be considered in the differential diagnosis. At the same time Ncadherin staining could be used to differentiate seminomas from embryonal carcinomas with solid components in metastatic GCTs, both having similar histopathological findings. On the other hand, the diagnostic value is not obvious for nonseminomatous tumors.


Assuntos
Antígenos CD/biossíntese , Caderinas/biossíntese , Neoplasias Embrionárias de Células Germinativas/metabolismo , Neoplasias Testiculares/metabolismo , Antígenos CD/metabolismo , Caderinas/metabolismo , Humanos , Masculino , Metástase Neoplásica , Neoplasias Embrionárias de Células Germinativas/patologia , Neoplasias Testiculares/patologia
5.
Int J Rheum Dis ; 17(6): 689-92, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24762098

RESUMO

Vasculitis is relatively uncommon in lymphoproliferative disease and may predate the diagnosis of lymphoproliferative disease. Many vasculitides have been associated with hairy cell leukemia (HCL), including polyarteritis nodosa (PAN) and leukocytoclastic vasculitis. We herein report a case whose initial presentation was like Behçet's disease (BD) (arthritis, oral and genital ulcerations, papulopustular skin lesions) in addition to pancytopenia, but turned out to have HCL. Because of the overlap between their symptoms, like oral ulcerations, skin lesions, arthritis and constitutional findings, HCL and BD may mimic each other. We should keep in mind other reasons for vasculitis such as lymphoproliferative disease, especially whose who have hematological abnormalities such as pancytopenia.


Assuntos
Síndrome de Behçet/diagnóstico , Leucemia de Células Pilosas/diagnóstico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Artrite/etiologia , Síndrome de Behçet/complicações , Biópsia , Cladribina/administração & dosagem , Diagnóstico Diferencial , Humanos , Imuno-Histoquímica , Leucemia de Células Pilosas/complicações , Leucemia de Células Pilosas/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Úlceras Orais/etiologia , Pancitopenia/etiologia , Síndromes Paraneoplásicas/etiologia , Valor Preditivo dos Testes , Prednisona/administração & dosagem , Escroto/patologia , Dermatopatias/etiologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA